Milne GL - Search Results

1

S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor.

Li MH, Sanchez T, Milne GL, Morrow JD, Hla T, Ferrer F. Li MH, et al. Among authors: milne gl. J Urol. 2009 Mar;181(3):1347-52. doi: 10.1016/j.juro.2008.10.140. Epub 2009 Jan 20. J Urol. 2009. PMID: 19157443 Free PMC article.

2

Quantification of F2-isoprostanes as a biomarker of oxidative stress.

Milne GL, Sanchez SC, Musiek ES, Morrow JD. Milne GL, et al. Nat Protoc. 2007;2(1):221-6. doi: 10.1038/nprot.2006.375. Nat Protoc. 2007. PMID: 17401357

3

Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Musiek ES, Milne GL, McLaughlin B, Morrow JD. Musiek ES, et al. Among authors: milne gl. Brain Pathol. 2005 Apr;15(2):149-58. doi: 10.1111/j.1750-3639.2005.tb00512.x. Brain Pathol. 2005. PMID: 15912888 Free PMC article. Review.

4

Isoprostanes and related compounds: update 2006.

Milne GL, Morrow JD. Milne GL, et al. Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1379-84. doi: 10.1089/ars.2006.8.1379. Antioxid Redox Signal. 2006. PMID: 16910785 Review.

5

Human biochemistry of the isoprostane pathway.

Milne GL, Yin H, Morrow JD. Milne GL, et al. J Biol Chem. 2008 Jun 6;283(23):15533-7. doi: 10.1074/jbc.R700047200. Epub 2008 Feb 19. J Biol Chem. 2008. PMID: 18285331 Free PMC article. Review. No abstract available.

6

Two pathways for cyclooxygenase-2 protein degradation in vivo.

Wada M, Saunders TL, Morrow J, Milne GL, Walker KP, Dey SK, Brock TG, Opp MR, Aronoff DM, Smith WL. Wada M, et al. Among authors: milne gl. J Biol Chem. 2009 Nov 6;284(45):30742-53. doi: 10.1074/jbc.M109.052415. Epub 2009 Sep 16. J Biol Chem. 2009. PMID: 19758985 Free PMC article.

7

The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation.

Milne GL, Musiek ES, Morrow JD. Milne GL, et al. Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):210-20. doi: 10.1089/ars.2005.7.210. Antioxid Redox Signal. 2005. PMID: 15650409 Review.

8

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.

Reckamp KL, Krysan K, Morrow JD, Milne GL, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA. Reckamp KL, et al. Among authors: milne gl. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3381-8. doi: 10.1158/1078-0432.CCR-06-0112. Clin Cancer Res. 2006. PMID: 16740761 Clinical Trial.

9

Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal.

Milne GL, Morrow JD, Picklo MJ Sr. Milne GL, et al. Neurosci Lett. 2006 Sep 25;405(3):172-4. doi: 10.1016/j.neulet.2006.06.058. Epub 2006 Jul 26. Neurosci Lett. 2006. PMID: 16875780

10

Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.

Milne GL, Yin H, Brooks JD, Sanchez S, Jackson Roberts L 2nd, Morrow JD. Milne GL, et al. Methods Enzymol. 2007;433:113-26. doi: 10.1016/S0076-6879(07)33006-1. Methods Enzymol. 2007. PMID: 17954231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters